News & Perspective

May 03, 2019

May 03, 2019

ASP Scan (Weekly) for May 03, 2019

Carbapenem reduction strategy
Quinolone ear drop risks
MDR Shigella in Vermont
US Candida auris uptick
Pause for antibiotic candidate
Fewer antibiotics for neonatal sepsis
Surgical prophylaxis risks
Rapid test for optimal antibiotics
CARB-X funding rounds
CRE infection outcomes
Reduced antibiotic for bacteriuria

Jul 27, 2018

Jul 27, 2018

ASP Scan (Weekly) for Jul 27, 2018

Iowa State AMR research center
Gram-negative ICU infections
Firm pares antibiotic R&D
Antibiotics for kids' LRTIs
Colistin resistance risk factors
Antifungal use in US hospitals
Pathogens in hurricane floodwaters
Antibiotic resistance in leeches
Candida auris uptick
MCR-1 on hospital surfaces
Antibiotic use in livestock
Forgotten antibiotics
ESBL colonization in travelers
Antibiotic redosing
Resistance trends in Swiss nursing homes
Antibiotic legislation nixed

Oct 21, 2016

Oct 21, 2016

News Scan for Oct 21, 2016

More MERS in Saudi Arabia
Zika funding offer
Antibiotic de-escalation
Hep A outbreak grows
Chikungunya update

Mar 02, 2009

Mar 02, 2009

H1N1 viruses gain Tamiflu resistance without losing fitness

(CIDRAP News) – Studies published today confirm that influenza A/H1N1 viruses have become widely resistant to oseltamivir (Tamiflu), the leading flu drug, without losing their ability to make people sick—thereby underlining the need for new antiviral drugs.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»